Vincristine Inj Tenders

corporations/Associations/Others

Tender For corrigendum : e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil ext-red-selected">inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50mg [152], methotrexate tab ip 2.5 mg [154], ext-red-selected">vincristine ext-red-selected">injection ip 1mg [159], atropine eye ointment ip 1%[319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine ext-red-selected">injection 500mg ip [529], ext-red-selected">inj. ganciclovir sodium 500mg (lyophilized powder forreconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant fviii 250 iuwith diluent [749], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension[nrd-103], hpmc 0.3%eye drop [nrd-104], chloramphenic ol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment[nrd-123], cabazitaxel ext-red-selected">injection 60 mg [nrd-167], fludarabine phosphate ext-red-selected">injection 100mg ext-red-selected">inj. ip [nrd-237], fludarabine phosphate ext-red-selected">injection 50mgext-red-selected">inj. ip [nrd-238], methotrexate 1000 mg ext-red-selected">inj. ip [nrd-289], ext-red-selected">inj. methylprednisol one acetate 125 mg i.p. (each vial contains methylprednisol one acetate 125mg) [nrd-292], mitomycin 40 mg ext-red-selected">inj. ip [nrd-297], omalizumab 150 mg vial ext-red-selected">inj. [nrd-321], plerixafor 24 mg ext-red-selected">inj. [nrd-338], recombinant lh 75iu ext-red-selected">inj. [nrd-351], trabectedin 1 mg ext-red-selected">inj. [nrd-387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule[nrd-794], ulipristal 5mg tab. [nrd-808], black disinfectant fluid (phenyl) as per scheduleo grade iii [398], phenobarbitone ext-red-selected">inj ip 200mg/ml [420], piperacillin + tazobactum for ext-red-selected">injection ip 4gm+500mg[468], decitabine 50 mg ext-red-selected">inj. [nrd-207], levosalbutamol 50mcg. and ipratropium40mcg. mdi [nrd-425], glycopegylated extended half life factor viii 1000 iu

corporations/Associations/Others

Tender For corrigendum : supply of drugs/medicines - cyclosporine tab/cap -each tab/cap to contain: cyclosporine 50mg., 5-fluorouracil ext-red-selected">inj-each vial to contain: fluorouracil ip 250mg, cytosine arabinoside ext-red-selected">inj-each vial to contain: cytosine arabinoside 100mg, packing: 1 vial, tamoxifen tab/cap-each tab/cap to contain: tamoxifen 10mg, bleomycin ext-red-selected">inj-each vial to contain: bleomycin ip 15iu, ext-red-selected">vincristine ext-red-selected">inj-each vial to contain: ext-red-selected">vincristine ip 1mg, doxorubicin ext-red-selected">inj-each 5 ml vial to contain: doxorubicin 10mg, methotrexate tab/cap-each tab/cap to contain: methotrexate ip 2.5mg, ifosfamide ext-red-selected">inj-each vial to contain: ifosfamide 1gm, flutamide tab/cap-each tab/cap to contain: flutamide 250mg, goserelin ext-red-selected">inj-each pfs to contain: goserelin 3.6mg packing: 1 pfs, vero cell culture rabies vaccine-each dose to contain: purified vero cell culture human rabies vaccine, methotrexate ext-red-selected">inj-each vial to contain: methotrexate ip 50mg, tamoxifen tab/cap-each tab/cap to contain:tamoxifen 20mg, tetanus vaccine (adsorbed)-each 0.5 ml to contain: tetanus toxoid 5/lfs, capd bag-each bag to contain: capd bag 7.5% of lcodextrin with asymmetrical y connector packing:2 ltr bag, human albumin 20% ext-red-selected">inj-each bottle to contain: human albumin 20% packing: 100ml bottle, anastrozole tab/cap-each tab/cap to contain: anastrozole 1mg, asparaginase ext-red-selected">inj-each vial to contain: asparaginase 10000 unit, methotrexate tab/cap-each tab/cap to contain: methotrexate 7.5mg, sorafenib tab/cap-each tab/cap to contain: sorafenib tosylate 200mg, immunoglobulin-each 1 ml solution to contain: active substance (s) human plasma proteins 50 mg, igm 6 mg (12%) , iga 6 mg (12%) igg 38 mg (76%), packing:10ml vial, anti-rabies vaccine-each ml to contain: hrg (rabies immunoglobulin (human)) 150iu, packing:2ml vial/amp/pfs, mycophenolate tab/cap-each tab/cap to contain: mycophenolic acid (as sodium salt) 540mg, leucovorin ext-red-selected">inj-each vial to contain: leucovorin 50mg, lenalidomide tab/cap-each tab/cap to contain: lenalidomide 5mg, zoledronic acid ext-red-selected">inj-each vial to contain: zoledronic acid 4mg, octreotide ext-red-selected">inj-each vial to contains: octreotide 30mg long acting release packing: 1 vial, ceritinib tab/cap-each tab/ hard gelatin cap to contain: ceritinib 150mg, ruxolitinib tab/cap-each tab/cap to contains ruxolitinib 15mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 20mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 5mg, nivolumab ext-red-selected">inj-each vial to contain: nivolumab 40mg packing: 1 vial, nivolumab ext-red-selected">inj-each vial to contain: nivolumab 100mg packing: 1 vial, crizotinib tab/cap-each hard gelatin tab/cap to contain : crizotinib 250mg, carfilzomib ext-red-selected">inj-each vial to contain: carfilzomib 60mg sterile lypholized powder packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 20 mg, afatinib tab/cap-each tab/cap to contain: afatinib 30 mg, axitinib tab/cap-each film coated tab/cap to contain: axitinib 5 mg, trabectedin ext-red-selected">inj-each vial to contain:trabectedin 1mg packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 40 mg, regorafenib tab/cap-each tab/cap to contain: regorafenib 40mg, recombinant human granulocyte ext-red-selected">inj-each ext-red-selected">inj to contain: recombinant human granulocyte macrophage colony stimulating factor (r-hu-gmcsf) 500microgram, degarelix ext-red-selected">inj-each vial to contain: degarelix 80 mg packing: 1 vial, erlotinib tab/cap-each tab/cap to contain: erlotinib 150 mg, everolimus tab/cap-each tab/cap to contains: everolimus 5 mg, secukinumab ext-red-selected">inj-each 1 ml to conatin: secukinumab 150mg, sucrose 92.43mg, l- histidine / l- histidine hcl monohydrate 4.656 mg, polysorbate 80 - 0.60mg.packing: 1 vial, tenofovir alafenamide tab/cap-each tab/cap to contains: tenofovir alafenamide 25mg, meningococcal vaccine-each vial to contain: meningococcal group (a,c,y and w135)polysachharide/oligosaccharide diphtheria toxoid conjugate vaccine,0.5 ml vial/pfs, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 4mg, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 10mg, ribociclib tab/cap-each film coated tab/cap

corporations/Associations/Others

Tender For short term e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil ext-red-selected">inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50 mg [152], methotrexate tab ip 2.5 mg [154], ext-red-selected">vincristine ext-red-selected">injection ip 1 mg [159], atropine eye ointment ip 1% [319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine ext-red-selected">injection 500 mg ip [529], ext-red-selected">inj. ganciclovir sodium 500mg (lyophilized powder for reconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant f viii 250 iu with diluent [749], brinozolamide 1% w/v and brimonidine tartrate 0.2% w/v ophthalmic suspension [nrd-98], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension [nrd-103], hpmc 0.3% eye drop [nrd-104], proparacaine 0.5% w/v eye drop usp [nrd-114], voriconazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119], chloramphenicol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment [nrd-123], cabazitaxel ext-red-selected">injection 60 mg [nrd-167], carmustine 100 mg ext-red-selected">inj. ip [nrd-175], fludarabine phosphate ext-red-selected">injection 100mg ext-red-selected">inj. ip [nrd-237], fludarabine phosphate ext-red-selected">injection 50mg ext-red-selected">inj. ip [nrd-238], methotrexate 1000 mg ext-red-selected">inj. ip [nrd-289], ext-red-selected">inj. methylprednisolone acetate 125 mg i.p. (each vial contains methylprednisolone acetate 125 mg) [nrd-292], mitomycin 40 mg ext-red-selected">inj. ip [nrd-297], omalizumab 150 mg vial ext-red-selected">inj. [nrd-321], plerixafor 24 mg ext-red-selected">inj. [nrd-338], rasburicase 1.5 mg ext-red-selected">inj. [nrd-347], recombinant lh 75iu ext-red-selected">inj. [nrd-351], trabectedin 1 mg ext-red-selected">inj. [nrd- 387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule [nrd-794], ulipristal 5mg tab. [nrd-808], glycopegylated extended half life factor viii 1000 iu